Abstract
CAR T cell therapy successes are challenged by several mechanisms of resistance including the development of dysfunctional states such as exhaustion. The features of CAR T cell exhaustion, its role in limiting the efficacy of CAR T therapy in both liquid and solid malignancies, and potential strategies to overcome it are discussed.
Originalsprache | Englisch |
---|---|
Seiten (von - bis) | 885-888 |
Seitenumfang | 4 |
Fachzeitschrift | Cancer Cell |
Jahrgang | 39 |
Ausgabenummer | 7 |
DOIs | |
Publikationsstatus | Veröffentlicht - 12 Juli 2021 |